StarFinder Lab invests in the most promising entrepreneurs and teams that develop highly innovative ‘Proof of Concept’ (POC) AI-BASED solutions for some of the most pressing global health challenges.
Powered by Roche and aMoon, we provide ACCESS, FUNDING and TOOLS through a uniquely tailored 9-month program and MORE if successful.
StarFinder is an exclusive innovation program for entrepreneurs to execute ‘Proof of Concept’ (POC) AI-based projects in order to address global Healthcare market needs.
Established in 2020 by Roche and aMoon Fund, this unique early stage investment program is aimed at identifying exceptional Israeli entrepreneurs who are addressing pressing global health challenges.
The collaboration, called “StarFinder Lab”, will provide funding, mentoring, data from HMOs and hospitals, unparalleled access to leading global expertise from within Roche and aMoon, personal office space at aMoon’s offices, and more. StarFinder is a 3 years program that will consist of three cohorts, each cohort will be composed of 3 selected ventures, each centered around a specific challenge.
Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible.
Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management. For more information, please visit www.roche.com
aMoon is a leading HealthTech and Life Sciences venture capital fund headquartered in Israel. Our mission is to launch tomorrow’s cures to the world’s greatest healthcare challenges. We are passionate about giving the most promising thinkers and innovators the resources they need to propel their business and technology to the next level and beyond. With over $1.1 billion under management, our mission is to harvest the tsunami of the convergence of health and technology and to accelerate cures for humanity’s most life-threatening conditions and global healthcare’s biggest cost drivers.
We know you can’t wait to apply for our second cohort,
and luckily December 8th is just around the corner.
Looking forward to receiving your
application on the 8th!